155 related articles for article (PubMed ID: 29191272)
21. Tumor-associated macrophages are a useful biomarker to predict recurrence after surgical resection of nonfunctional pancreatic neuroendocrine tumors.
Wei IH; Harmon CM; Arcerito M; Cheng DF; Minter RM; Simeone DM
Ann Surg; 2014 Dec; 260(6):1088-94. PubMed ID: 25389924
[TBL] [Abstract][Full Text] [Related]
22. Nonfunctioning neuroendocrine tumors of the pancreas: clinical presentation of 7 patients.
Closset J; Delhaye M; Sperduto N; Rickaert F; Gelin M
Hepatogastroenterology; 1996; 43(12):1640-4. PubMed ID: 8975980
[TBL] [Abstract][Full Text] [Related]
23. [Peculiarities of diagnosis and surgical treatment of nonfunctioning neuroendocrine pancreatic tumors].
Nychytaĭlo MIu; Skums AV; Shkarban VP; Iurevych VV; Shkarban PO; Skums AA
Klin Khir; 2013 Dec; (12):5-9. PubMed ID: 24501999
[TBL] [Abstract][Full Text] [Related]
24. Determinants of surgical resection for pancreatic neuroendocrine tumors.
Doi R
J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):610-7. PubMed ID: 25773163
[TBL] [Abstract][Full Text] [Related]
25. Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005.
Vagefi PA; Razo O; Deshpande V; McGrath DJ; Lauwers GY; Thayer SP; Warshaw AL; Fernández-Del Castillo C
Arch Surg; 2007 Apr; 142(4):347-54. PubMed ID: 17438169
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic neuroendocrine tumors: accurate grading with Ki-67 index on fine-needle aspiration specimens using the WHO 2010/ENETS criteria.
Farrell JM; Pang JC; Kim GE; Tabatabai ZL
Cancer Cytopathol; 2014 Oct; 122(10):770-8. PubMed ID: 25044931
[TBL] [Abstract][Full Text] [Related]
27. Surgical Management of Pancreatic Neuroendocrine Tumors.
Chiruvella A; Kooby DA
Surg Oncol Clin N Am; 2016 Apr; 25(2):401-21. PubMed ID: 27013372
[TBL] [Abstract][Full Text] [Related]
28. Pancreatic cystic endocrine tumors: a different morphological entity associated with a less aggressive behavior.
Boninsegna L; Partelli S; D'Innocenzio MM; Capelli P; Scarpa A; Bassi C; Pederzoli P; Falconi M
Neuroendocrinology; 2010; 92(4):246-51. PubMed ID: 20689265
[TBL] [Abstract][Full Text] [Related]
29. Small, nonfunctioning, asymptomatic pancreatic neuroendocrine tumors (PNETs): role for nonoperative management.
Lee LC; Grant CS; Salomao DR; Fletcher JG; Takahashi N; Fidler JL; Levy MJ; Huebner M
Surgery; 2012 Dec; 152(6):965-74. PubMed ID: 23102679
[TBL] [Abstract][Full Text] [Related]
30. Parenchyma-preserving resections for small nonfunctioning pancreatic endocrine tumors.
Falconi M; Zerbi A; Crippa S; Balzano G; Boninsegna L; Capitanio V; Bassi C; Di Carlo V; Pederzoli P
Ann Surg Oncol; 2010 Jun; 17(6):1621-7. PubMed ID: 20162460
[TBL] [Abstract][Full Text] [Related]
31. Pancreatic incidentalomas: a growing clinical challenge exemplified by an intrapancreatic accessory spleen.
Matthaei H; Schmelzle M; Braunstein S; Bölke E; Peiper M
Wien Klin Wochenschr; 2011 Mar; 123(5-6):186-8. PubMed ID: 21365270
[TBL] [Abstract][Full Text] [Related]
32. Pattern and clinical predictors of lymph node involvement in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs).
Partelli S; Gaujoux S; Boninsegna L; Cherif R; Crippa S; Couvelard A; Scarpa A; Ruszniewski P; Sauvanet A; Falconi M
JAMA Surg; 2013 Oct; 148(10):932-9. PubMed ID: 23986355
[TBL] [Abstract][Full Text] [Related]
33. [Surgery for pancreatic neuroendocrine tumors].
Shibata C; Egawa S; Motoi F; Morikawa T; Naitoh T; Unno M; Sasaki I
Nihon Geka Gakkai Zasshi; 2012 Nov; 113(6):502-6. PubMed ID: 23330458
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of nasopancreatic stenting prior to laparoscopic enucleation of pancreatic neuroendocrine tumor.
Misawa T; Imazu H; Fujiwara Y; Kitamura H; Tsutsui N; Ito R; Shiba H; Futagawa Y; Wakiyama S; Ishida Y; Yanaga K
Asian J Endosc Surg; 2013 May; 6(2):140-2. PubMed ID: 23602001
[TBL] [Abstract][Full Text] [Related]
35. Surgical treatment of incidentally identified pancreatic masses.
Fitzgerald TL; Smith AJ; Ryan M; Atri M; Wright FC; Law CH; Hanna SS
Can J Surg; 2003 Dec; 46(6):413-8. PubMed ID: 14680347
[TBL] [Abstract][Full Text] [Related]
36. Management of cystic and solid pancreatic incidentalomas: a review analysis.
Karatzas T; Dimitroulis D; Charalampoudis P; Misiakos EP; Vasileiadis I; Kouraklis G
J BUON; 2013; 18(1):17-24. PubMed ID: 23613384
[TBL] [Abstract][Full Text] [Related]
37. Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas.
Matthews BD; Heniford BT; Reardon PR; Brunicardi FC; Greene FL
Am Surg; 2000 Dec; 66(12):1116-22; discussion 1122-3. PubMed ID: 11149582
[TBL] [Abstract][Full Text] [Related]
38. Standard pre- and postoperative determination of chromogranin a in resectable non-functioning pancreatic neuroendocrine tumors--diagnostic accuracy: NF-pNET and low tumor burden.
Jilesen AP; Busch OR; van Gulik TM; Gouma DJ; Nieveen van Dijkum EJ
Dig Surg; 2014; 31(6):407-14. PubMed ID: 25572908
[TBL] [Abstract][Full Text] [Related]
39. [Cystic pancreatic tumor treated by distal spleno-pancreatectomy with occasional diagnosis of neuroendocrine tumor: case report].
Pala C; Serventi F; Scognamillo F; Attene F; Pisano IP; Cugia L; Meloni M; Trignano M
Ann Ital Chir; 2008; 79(6):451-6. PubMed ID: 19354042
[TBL] [Abstract][Full Text] [Related]
40. Laparoscopy assisted middle-segment-preserving pancreatectomy for multiple pancreatic neuroendocrine tumors: report of a case.
Usui M; Kuriyama N; Uchida K; Kishiwada M; Mizuno S; Sakurai H; Tabata M; Shiraishi T; Isaji S
Asian J Endosc Surg; 2014 Aug; 7(3):271-4. PubMed ID: 25131327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
